Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ketamine Infusion for Neuropathic Pain in Brachial Plexus Injuries
Sponsor: Mayo Clinic
Summary
The purpose of this study is to assess pre- and postoperative neuropathic pain in patients with traumatic brachial plexus injuries to determine if intraoperative ketamine infusion affect neuropathic pain associated with avulsion injuries of the brachial plexus.
Official title: Ketamine Infusion for Treatment of Chronic Neuropathic Pain in Traumatic Brachial Plexus Injuries, a Prospective Randomized Control Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2021-12-15
Completion Date
2026-12
Last Updated
2025-04-02
Healthy Volunteers
No
Conditions
Interventions
Ketamine Infustion
Intravenous infusion at 0.5 mg/kg/hr from induction to emergence from anesthesia during the subject's brachial plexus reconstruction surgery. In addition, subjects will receive postoperative ketamine infusion of 0.1-0.3 mg/kg/hr for 24 hours titrated to side effects while patients are admitted to the hospital following surgery.
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States